MAPT and Mental deterioration: ApoB from cerebrospinal fluid sample was identified as an important marker for tau pathology and cognitive decline,27 which reinforces the need for considering apolipoproteins in clinical practice, and these findings may also be useful for designing more effective drug interventions.